insights_auto
Why is KROS down 2,62%?
Dive Deeperchevron_right
KROS:NASDAQ
Keros Therapeutics Inc
10,03 $
arrow_downward
-2,62%(-0,27) 1D
10,18 $
arrow_upward
+1,50% (+0,15)bedtimeAfter hours
Closed: 16 қар., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KROS...
Open
10,33 $
High
10,74 $
Low
9,90 $
Mkt. cap
196,83 млн
Avg. vol.
184,55 м.
Volume
193,88 м.
52-wk high
22,55 $
52-wk low
8,98 $
EPS
-2,83 $
Beta
1,13
Shares outstanding
19,62 млн
No. of employees
87
Open
10,33 $
High
10,74 $
Low
9,90 $
Mkt. cap
196,83 млн
Avg. vol.
184,55 м.
Volume
193,88 м.
52-wk high
22,55 $
52-wk low
8,98 $
EPS
-2,83 $
Beta
1,13
Shares outstanding
19,62 млн
No. of employees
87
News stories
From web sources and news partners
marketscreener.com
·
17 минут бұрын
Keros Therapeutics Authorizes $5 Million Share Repurchase Program
Investing.com
·
1 сағат бұрын
Keros Therapeutics approves $5M share buyback program
Yahoo! Finance Canada
·
1 сағат бұрын
Keros Therapeutics Announces Additional $5 Million Share Repurchase Authorization
Zacks
·
6 сағат бұрын
Novartis' Cosentyx Gets Positive CHMP Opinion for Adolescents With HS
About Keros Therapeutics Inc
CEO-
Employees87
Founded2015
HeadquartersЛексингтон, Массачусетс, Америка Құрама Штаттары
SectorHealth Care
Industry-
Websitekerostx.com